EBC Financial Group Enhances Liquidity and Lowers Trading Costs on Major Stock Indices
11 oct. 2024 05h44 HE
|
EBC Financial Group
EBC is enhancing liquidity for five major stock indices, allowing investors to benefit from lower trading costs during a global market resurgence.
Cingulate Initiates Final Study for Lead ADHD Asset CTx-1301
12 sept. 2024 08h30 HE
|
Cingulate Inc.
KANSAS CITY, Kan., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
Cingulate Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update
08 mai 2024 07h00 HE
|
Cingulate Inc.
CTx-1301 on track to file for Marketing Approval with FDA in 1H 2025 Increase of $10 Million in Stockholders’ Equity KANSAS CITY, Kan., May 08, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:...
Westhaven Announces $2,300,000 Non-Brokered Private Placement
20 févr. 2024 16h01 HE
|
Westhaven Gold Corp.
VANCOUVER, British Columbia, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Westhaven Gold Corp. (TSX-V: WHN) is pleased to announce that it has arranged to issue, on a non-brokered private placement basis, up...
Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of Directors
13 févr. 2024 06h45 HE
|
Cingulate Inc.
KANSAS CITY, Kan., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
Cingulate to Participate in Benzinga All Live Access Event
14 avr. 2023 14h00 HE
|
Cingulate Inc.
KANSAS CITY, Kan., April 14, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
Cingulate Completes First Cohort of Phase 3 Adult Onset and Duration Trial of CTx-1301 (dexmethylphenidate) for ADHD
04 avr. 2023 06h45 HE
|
Cingulate Inc.
Trial On Track for 3Q 2023 Results Pivotal Phase 3 Trial in Pediatric/Adolescent Patients Planned to Begin Mid-2023 KANSAS CITY, Kan., April 04, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:...
Dow Jones Launches Agency Roster Review
14 mars 2023 09h00 HE
|
Dow Jones & Company
NEW YORK, March 14, 2023 (GLOBE NEWSWIRE) -- Dow Jones, publisher of The Wall Street Journal, Barron’s, MarketWatch and more, is undertaking a full agency review across its consumer brands and its...
CSX Recognized by Dow Jones Sustainability Index
18 nov. 2020 14h15 HE
|
CSX Corporation
JACKSONVILLE, Fla., Nov. 18, 2020 (GLOBE NEWSWIRE) -- CSX continues to build its reputation in sustainability, earning a place on the Dow Jones Sustainability Index (DJSI) North America for the 10th...
Dual Shockwaves of Pandemic, Digital Disruption Altering Course of Global Business
02 nov. 2020 11h00 HE
|
Information Services Group, Inc.
STAMFORD, Conn., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Leaders with the International Monetary Fund, Starbucks, Freshly and the National Cyber Security Alliance will be among the featured speakers at...